News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
272 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (24953)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (202)
2 (163)
3 (150)
4 (1)
6 (113)
7 (192)
8 (195)
9 (146)
10 (94)
11 (1)
12 (5)
13 (183)
14 (272)
15 (209)
16 (183)
17 (86)
18 (3)
19 (5)
20 (142)
21 (207)
22 (173)
23 (165)
24 (67)
25 (3)
26 (3)
27 (139)
28 (227)
29 (177)
30 (210)
31 (85)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2018
ESSA Pharma Inc. is a pharmaceutical company focused on developing novel therapies for the treatment of prostate cance
August 14, 2018
·
11 min read
Biotech Bay
CAPP Presents Roadmap for Telehealth Adoption to Improve Patient Care
New Primer Recommends Transformation of Telehealth into a Business Model
August 14, 2018
·
3 min read
Business
“The Story of a Face": National Geographic Unveils Youngest Full-Face Transplant Recipient in American History
With unprecedented access granted by the Cleveland Clinic, National Geographic dedicated more than two years exclusively documenting this groundbreaking scientific journey
August 14, 2018
·
5 min read
Business
GTx Provides Corporate Update and Reports Second Quarter 2018 Financial Results
Completed patient enrollment in the ASTRID Trial, a Phase 2 double-blinded, placebo-controlled clinical trial of enobosarm in Stress Urinary Incontinence
August 14, 2018
·
10 min read
Business
Acorda Announces Management Transitions
Acorda Therapeutics, Inc. announced that Rick Batycky, Ph.D., Chief Technology Officer, will be leaving Acorda as of August 20, 2018 to take a position as the CEO of a private, venture-backed biotechnology company.
August 14, 2018
·
5 min read
Job Trends
New Doula Agency, AlloTribe Launches First-of-its-Kind Full Spectrum Training in Colorado
AlloTribe launches “womb-to-two” certified doula training covering birth and postpartum care in a 2-day seminar
August 14, 2018
·
1 min read
Business
DASH Analytics High Definition Care Platform Chosen for CDC Epicenter Trial in Surgical Site Infection
The multicenter trial will assess the efficacy of using negative pressure wound therapy in preventing surgical site infections.
August 14, 2018
·
2 min read
Business
Iterum Reports Second Quarter 2018 Financial Results and Recent Highlights
As of June 30, 2018, Iterum had cash, cash equivalents and short-term investments of $135.3 million and approximately 14.2 million shares outstanding
August 14, 2018
·
7 min read
Business
Bionik Laboratories Reports First Quarter Fiscal 2019 Financial Results
Reported sales of $501,333, up substantially from $87,520 in the prior-year quarter
August 14, 2018
·
22 min read
BioMidwest
OmniTier’s CompStor™ Brings De Novo Analytics to Genomics
Researchers in joint study cut time for de novo global assembly to under two hours with CompStor’s tiered-memory architecture; higher accuracy and a faster path to precision medicine.
August 14, 2018
·
4 min read
Previous
6 of 28
Next